GlassScriptPhysician profile
Ahmed Saeed
NPI 1033423744
$245,887.63
in general payments reported to CMS, 2019-2025
31 companies · $76K in 2025
The $76K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,356 · 2020: $496 · 2021: $1,825 · 2022: $31K · 2023: $52K · 2024: $80K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $70K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Consulting Fee: $48K · Travel and Lodging: $18K · Food and Beverage: $7,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $69,775.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,496.16 |
| Consulting Fee | $47,955.55 |
| Travel and Lodging | $18,145.78 |
| Food and Beverage | $7,637.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $84,043.90 | 2019-2025 | Disposable Distal Attachment, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Boston Scientific Corporation | $55,023.16 | 2019-2025 | General - Therapies, Resolution 360 Clip, Orise |
| Olympus America INC. | $42,107.74 | 2021-2025 | Endoclot Phs, Evis Exera III Video System Center, Endoclot Sis |
| Endogastric Solutions, INC | $24,915.57 | 2019-2024 | Esophyx |
| Medtronic, INC. | $22,210.74 | 2021-2025 | Gi Genius, Barrx, Endoflip |
| Merit Medical Systems INC | $6,045.49 | 2024-2025 | Esophyx |
| Lumendi LLC | $3,333.52 | 2022-2024 | |
| Olympus Medical Systems Corporation | $2,863.97 | 2024-2025 | Single Use Repositionable Clip |
| Olympus Corporation | $2,028.60 | 2023 | |
| Apollo Endosurgery US INC | $1,001.16 | 2019 | |
| Abbvie INC. | $546.76 | 2019-2025 | Mavyret |
| Covidien LP | $336.32 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $270.95 | 2021-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $210.17 | 2020-2025 | Tremfya, Stelara |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $158.70 | 2019-2025 | |
| Ethicon US, LLC | $152.96 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.85 | 2019-2023 | Uceris, Trulance |
| Celgene Corporation | $76.23 | 2021-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $39.56 | 2025 | Voquezna |
| Daiichi Sankyo INC. | $32.98 | 2019 | |
| Capsovision, INC. | $32.30 | 2024 | Capsocam Plus |
| Regeneron Healthcare Solutions, INC. | $31.86 | 2025 | Dupixent |
| Braintree Laboratories, INC. | $30.22 | 2020-2024 | Sutab, Suflave |
| Micro-Tech Endoscopy USA, INC. | $29.44 | 2022-2024 | Edgehog, Eyemax |
| Astrazeneca Pharmaceuticals LP | $25.85 | 2023 | Imfinzi |
| Novo Nordisk INC | $23.03 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $19.50 | 2021 | |
| Aimmune Therapeutics, INC. | $19.08 | 2025 | Zenpep |
| Celltrion USA INC. | $18.95 | 2025 | Vegzelma |
| Intercept Pharmaceuticals, INC. | $16.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.